Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia

BACKGROUND: Hydromethylthionine is a potent inhibitor of pathological aggregation of tau and TDP-43 proteins. OBJECTIVE: To compare hydromethylthionine treatment effects at two doses and to determine how drug exposure is related to treatment response in bvFTD. METHODS: We undertook a 52-week Phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiells, Helen, Schelter, Bjoern O., Bentham, Peter, Baddeley, Thomas C., Rubino, Christopher M., Ganesan, Harish, Hammel, Jeffrey, Vuksanovic, Vesna, Staff, Roger T., Murray, Alison D., Bracoud, Luc, Wischik, Damon J., Riedel, Gernot, Gauthier, Serge, Jia, Jianping, Moebius, Hans J., Hardlund, Jiri, Kipps, Christopher M., Kook, Karin, Storey, John M.D., Harrington, Charles R., Wischik, Claude M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306898/
https://www.ncbi.nlm.nih.gov/pubmed/32280089
http://dx.doi.org/10.3233/JAD-191173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306898/
https://www.ncbi.nlm.nih.gov/pubmed/32280089
http://dx.doi.org/10.3233/JAD-191173

Ejemplares similares